Lupin is a USD 2.06 billion innovation led transnational pharmaceutical major producing and developing a wide range of branded and generic formulations as well as biotechnology products and APIs globally. The Company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership positions in the Anti-TB and Cephalosporin segment.
Lupin is the 6th largest and fastest growing top 5 generics player in the US (5.3% market share by prescriptions, IMS Health) and the 3rd largest Indian pharmaceutical company by sales. The Company is also the fastest growing top 10 generic pharmaceutical players in Japan and South Africa (IMS).
For the financial year ended March 2014, Lupin's Consolidated turnover and Profit after Tax were Rs. 120,600 million (USD 2.06 billion) and Rs. 18,364 million (USD 393 million) respectively.
Market capitalization (14-Sept-2020)
Closing stock price (14-Sept-2020)
Lupin has 26 Twitter Followers. The number of followers has decreased 3.7% month over month and increased 9.9% quarter over quarter
When was Lupin founded?
Lupin was founded in 1968.
Who are Lupin key executives?
Lupin's key executives are Manju D Gupta, Kamal K Sharma and Vinita Gupta.
How many employees does Lupin have?
Lupin has 18,302 employees.
Who are Lupin competitors?
Competitors of Lupin include Mito BioPharma, Patagonia Pharmaceuticals and Sciwind.
Where is Lupin headquarters?
Lupin headquarters is located at Laxmi Towers BKC Road, Mumbai.
Where are Lupin offices?
Lupin has offices in Mumbai, Baltimore and Zug.
How many offices does Lupin have?
Lupin has 4 offices.
Receive alerts for 300+ data fields across thousands of companies